|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000124207 |
Summary for CSE1L |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000124207 | Gene symbol | CSE1L |
| Gene name | chromosome segregation 1 like | |
| HGNC | 2431 | |
| Entrez ID | 1434 | |
| Gene type | protein_coding | |
| Synonyms | CSE1L|CAS|XPO2|CSE1 | |
| UniProtAcc | P55060 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for CSE1L |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| CSE1L | 6.92e+03 | 1.49e+00 | 2.40e-01 | 6.23e+00 | 4.73e-10 | 1.07e-08 | READ |
Top |
Sex-biased somatic mutation for CSE1L |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for CSE1L |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| LIHC | cg00340382 | chr20:49045869 | CGI:chr20:49046195-49046912 | promoter | 1.64e-01 | 2.76e-01 | -5.79e+00 | 6.87e-09 | 5.88e-08 | -1.11e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Top |
Exon skipping events with PSI in TCGA for CSE1L |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Landscape of exon skipping events across multiple cancer types. |
 |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for CSE1L |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for CSE1L |
| TFs related to CSE1L. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| ACC | PRDM6 | CSE1L | 4.01e+00 | 9.87e-01 | 2.78e+00 | 1.55e-03 | Male-biased |
| ACC | ZNF182 | CSE1L | 4.23e+00 | 9.89e-01 | 3.11e+00 | 2.61e-03 | Male-biased |
| ACC | ZNF22 | CSE1L | 4.23e+00 | 9.90e-01 | 3.06e+00 | 2.06e-03 | Male-biased |
| ACC | ZNF225 | CSE1L | 4.20e+00 | 9.90e-01 | 2.93e+00 | 1.34e-03 | Male-biased |
| ACC | ZNF235 | CSE1L | 4.20e+00 | 9.91e-01 | 2.89e+00 | 1.14e-03 | Male-biased |
| ACC | ZNF287 | CSE1L | 4.25e+00 | 9.91e-01 | 3.01e+00 | 1.53e-03 | Male-biased |
| ACC | ZNF384 | CSE1L | 3.97e+00 | 9.85e-01 | 2.88e+00 | 2.75e-03 | Male-biased |
| ACC | ZNF487 | CSE1L | 4.13e+00 | 9.89e-01 | 2.98e+00 | 2.19e-03 | Male-biased |
| ACC | ZNF613 | CSE1L | 4.11e+00 | 9.88e-01 | 3.02e+00 | 2.90e-03 | Male-biased |
| BLCA | ZNF225 | CSE1L | 4.17e+00 | 9.80e-01 | 3.31e+00 | 7.69e-03 | Male-biased |
| BLCA | ZNF235 | CSE1L | 4.22e+00 | 9.82e-01 | 3.33e+00 | 7.19e-03 | Male-biased |
| BLCA | ZNF79 | CSE1L | 4.16e+00 | 9.86e-01 | 2.83e+00 | 1.58e-03 | Male-biased |
| ESCA | ZNF121 | CSE1L | 4.30e+00 | 9.84e-01 | 3.55e+00 | 8.42e-03 | Male-biased |
| ESCA | ZNF181 | CSE1L | 4.24e+00 | 9.83e-01 | 3.50e+00 | 9.09e-03 | Male-biased |
| ESCA | ZNF22 | CSE1L | 4.13e+00 | 9.84e-01 | 3.35e+00 | 6.62e-03 | Male-biased |
| ESCA | ZNF235 | CSE1L | 3.98e+00 | 9.81e-01 | 3.18e+00 | 5.87e-03 | Male-biased |
| ESCA | ZNF443 | CSE1L | 4.36e+00 | 9.85e-01 | 3.60e+00 | 7.68e-03 | Male-biased |
| ESCA | ZNF496 | CSE1L | 4.28e+00 | 9.86e-01 | 3.49e+00 | 6.51e-03 | Male-biased |
| MESO | ZNF182 | CSE1L | 3.99e+00 | 9.85e-01 | 2.07e+00 | 7.96e-04 | Male-biased |
| MESO | ZNF22 | CSE1L | 4.03e+00 | 9.86e-01 | 2.11e+00 | 7.96e-04 | Male-biased |
| MESO | ZNF225 | CSE1L | 3.84e+00 | 9.80e-01 | 2.02e+00 | 1.11e-03 | Male-biased |
| MESO | ZNF235 | CSE1L | 3.92e+00 | 9.83e-01 | 2.11e+00 | 1.18e-03 | Male-biased |
| MESO | ZNF287 | CSE1L | 3.86e+00 | 9.80e-01 | 2.15e+00 | 1.68e-03 | Male-biased |
| MESO | ZNF443 | CSE1L | 4.17e+00 | 9.80e-01 | 2.93e+00 | 8.49e-03 | Male-biased |
| MESO | ZNF613 | CSE1L | 3.87e+00 | 9.81e-01 | 2.07e+00 | 1.24e-03 | Male-biased |
| PCPG | ZNF79 | CSE1L | 4.06e+00 | 1.36e-02 | 4.80e+00 | 9.82e-01 | Female-biased |
| CSE1L related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for CSE1L |
| RBPs related to ES in CSE1L. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| STAD | QKI | exon_skip_352895 | 1.17e+01 | 9.89e-01 | 1.13e+01 | 9.96e-03 | Male-biased |
| UVM | TARDBP | exon_skip_352881 | 7.26e+00 | 5.99e-03 | 7.60e+00 | 9.84e-01 | Female-biased |
| THYM | QKI | exon_skip_352895 | 1.28e+01 | 9.99e-01 | 1.22e+01 | 5.38e-04 | Male-biased |
| LIHC | SRSF9 | exon_skip_352880 | 8.28e+00 | 9.86e-01 | 7.84e+00 | 6.75e-03 | Male-biased |
| LIHC | ZFP36 | exon_skip_352893 | 9.00e+00 | 1.27e-02 | 9.36e+00 | 9.84e-01 | Female-biased |
| LUAD | ANKHD1 | exon_skip_352892 | 1.27e+01 | 3.17e-03 | 1.31e+01 | 9.97e-01 | Female-biased |
| LUAD | QKI | exon_skip_352895 | 1.18e+01 | 1.44e-03 | 1.23e+01 | 9.98e-01 | Female-biased |
| CHOL | ANKHD1 | exon_skip_352892 | 1.41e+01 | 9.96e-01 | 1.36e+01 | 3.45e-03 | Male-biased |
| CHOL | SRSF9 | exon_skip_352880 | 8.41e+00 | 9.84e-01 | 7.99e+00 | 8.92e-03 | Male-biased |
| BRCA | ANKHD1 | exon_skip_352892 | 1.32e+01 | 9.84e-01 | 1.27e+01 | 1.59e-02 | Male-biased |
| ESCA | ANKHD1 | exon_skip_352892 | 1.25e+01 | 5.67e-03 | 1.30e+01 | 9.94e-01 | Female-biased |
| ESCA | QKI | exon_skip_352895 | 1.20e+01 | 9.97e-01 | 1.13e+01 | 2.81e-03 | Male-biased |
| THCA | ANKHD1 | exon_skip_352892 | 1.33e+01 | 9.99e-01 | 1.28e+01 | 3.18e-04 | Male-biased |
| THCA | BRUNOL4 | exon_skip_352892 | 7.57e+00 | 9.81e-01 | 7.27e+00 | 9.48e-03 | Male-biased |
| THCA | BRUNOL5 | exon_skip_352892 | 7.58e+00 | 9.81e-01 | 7.28e+00 | 9.53e-03 | Male-biased |
| THCA | hnRNPLL | exon_skip_352892 | 7.49e+00 | 9.80e-01 | 7.19e+00 | 9.61e-03 | Male-biased |
| THCA | QKI | exon_skip_352895 | 1.21e+01 | 9.98e-01 | 1.17e+01 | 1.22e-03 | Male-biased |
| PCPG | ANKHD1 | exon_skip_352892 | 1.30e+01 | 9.97e-01 | 1.26e+01 | 2.72e-03 | Male-biased |
| MESO | ANKHD1 | exon_skip_352892 | 1.28e+01 | 9.99e-01 | 1.22e+01 | 8.78e-04 | Male-biased |
| MESO | BRUNOL4 | exon_skip_352892 | 7.67e+00 | 9.84e-01 | 7.27e+00 | 6.29e-03 | Male-biased |
| MESO | BRUNOL5 | exon_skip_352892 | 7.68e+00 | 9.84e-01 | 7.28e+00 | 6.30e-03 | Male-biased |
| MESO | hnRNPLL | exon_skip_352892 | 7.59e+00 | 9.84e-01 | 7.19e+00 | 6.26e-03 | Male-biased |
| MESO | QKI | exon_skip_352895 | 1.20e+01 | 1.81e-03 | 1.25e+01 | 9.98e-01 | Female-biased |
| MESO | ZFP36 | exon_skip_352893 | 9.13e+00 | 1.69e-02 | 9.44e+00 | 9.80e-01 | Female-biased |
| GBM | ANKHD1 | exon_skip_352892 | 1.26e+01 | 4.39e-03 | 1.30e+01 | 9.95e-01 | Female-biased |
| GBM | BRUNOL4 | exon_skip_352892 | 7.31e+00 | 9.75e-03 | 7.65e+00 | 9.80e-01 | Female-biased |
| GBM | BRUNOL5 | exon_skip_352892 | 7.32e+00 | 9.74e-03 | 7.67e+00 | 9.80e-01 | Female-biased |
| GBM | hnRNPLL | exon_skip_352892 | 7.23e+00 | 9.81e-03 | 7.57e+00 | 9.80e-01 | Female-biased |
| PAAD | QKI | exon_skip_352895 | 1.20e+01 | 3.56e-04 | 1.26e+01 | 9.99e-01 | Female-biased |
| KIRC | QKI | exon_skip_352895 | 1.16e+01 | 1.56e-03 | 1.21e+01 | 9.98e-01 | Female-biased |
| KICH | ZFP36 | exon_skip_352893 | 8.83e+00 | 4.18e-03 | 9.23e+00 | 9.92e-01 | Female-biased |
| BLCA | ANKHD1 | exon_skip_352892 | 1.29e+01 | 3.97e-03 | 1.33e+01 | 9.96e-01 | Female-biased |
| SKCM | QKI | exon_skip_352895 | 1.17e+01 | 4.77e-03 | 1.21e+01 | 9.95e-01 | Female-biased |
| HNSC | ANKHD1 | exon_skip_352892 | 1.22e+01 | 1.29e-03 | 1.27e+01 | 9.98e-01 | Female-biased |
| HNSC | QKI | exon_skip_352895 | 1.16e+01 | 4.10e-04 | 1.22e+01 | 9.99e-01 | Female-biased |
| SARC | ANKHD1 | exon_skip_352892 | 1.32e+01 | 9.96e-01 | 1.27e+01 | 3.58e-03 | Male-biased |
| SARC | QKI | exon_skip_352895 | 1.26e+01 | 9.97e-01 | 1.21e+01 | 2.52e-03 | Male-biased |
| CSE1L related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs6012228 | chr20:47629475:G:A | - | 0.216503603605562 | 0.015767562680002 | PAAD | Female-baised eQTL |
| rs6018606 | chr20:47634250:G:A | - | 0.216503603605562 | 0.015767562680002 | PAAD | Female-baised eQTL |
| rs2273022 | chr20:47627456:C:G | - | 0.200956959052454 | 0.031624837419004 | PAAD | Female-baised eQTL |
| rs6018602 | chr20:47632341:A:G | - | 0.200956959052454 | 0.031624837419004 | PAAD | Female-baised eQTL |
| rs6012229 | chr20:47632730:C:T | - | 0.200956959052454 | 0.031624837419004 | PAAD | Female-baised eQTL |
| rs6018603 | chr20:47633106:T:C | - | 0.200956959052454 | 0.031624837419004 | PAAD | Female-baised eQTL |
| rs6069656 | chr20:56224751:A:T | - | -0.301592862223349 | 0.000649404827431967 | GBM | Female-baised eQTL |
| rs4811677 | chr20:56225947:G:C | - | -0.179773695842614 | 0.0198986180654914 | GBM | Female-baised eQTL |
| rs4811678 | chr20:56225976:C:A | - | -0.179773695842614 | 0.0198986180654914 | GBM | Female-baised eQTL |
| rs4811680 | chr20:56226159:A:G | - | -0.179773695842614 | 0.0198986180654914 | GBM | Female-baised eQTL |
| rs66870733 | chr20:56227533:A:G | - | 0.173917920484163 | 0.048531312190192 | GBM | Female-baised eQTL |
| rs4811681 | chr20:56226316:G:A | - | -0.173917920484163 | 0.048531312190192 | GBM | Female-baised eQTL |
| rs6069663 | chr20:56227803:T:A | - | -0.173917920484163 | 0.048531312190192 | GBM | Female-baised eQTL |
| rs4589822 | chr20:56228669:G:A | - | -0.173917920484163 | 0.048531312190192 | GBM | Female-baised eQTL |
| rs1853917 | chr20:56228772:G:A | - | -0.173917920484163 | 0.048531312190192 | GBM | Female-baised eQTL |
| rs1276444 | chr20:56960082:T:C | - | 0.220279621410685 | 0.0483148080201629 | LIHC | Female-baised eQTL |
| rs62200258 | chr20:47768731:G:A | - | 0.200454242020173 | 0.0338766776504541 | STAD | Female-baised eQTL |
| rs244104 | chr20:44591335:T:C | - | 0.148631631117191 | 0.0397597878267783 | STAD | Female-baised eQTL |
| rs218463 | chr20:58637485:G:A | - | -0.0841524467692635 | 0.0322461298991628 | COAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs7352741 | chr20:57228093:C:T | - | 0.044225471141343 | 0.0028536013045737 | KIRC | Male-baised eQTL |
| rs35468019 | chr20:57227041:G:A | - | 0.0437888749912095 | 0.00321864517005887 | KIRC | Male-baised eQTL |
| rs17404303 | chr20:57228631:C:T | - | 0.0435386176168345 | 0.00463226917547692 | KIRC | Male-baised eQTL |
| rs55977030 | chr20:57230111:G:A | - | 0.0435386176168345 | 0.00463226917547692 | KIRC | Male-baised eQTL |
| rs6070031 | chr20:57225881:C:T | - | 0.0430246694247757 | 0.00518502370913491 | KIRC | Male-baised eQTL |
| rs6122778 | chr20:49267405:T:A | - | 0.0400904469806706 | 0.0133338350267294 | KIRC | Male-baised eQTL |
| rs8123651 | chr20:57239192:T:C | - | 0.039819136393293 | 0.0172657624990057 | KIRC | Male-baised eQTL |
| rs8117076 | chr20:57239421:C:T | - | 0.039819136393293 | 0.0172657624990057 | KIRC | Male-baised eQTL |
| rs62205689 | chr20:57238549:C:T | - | 0.0396952282695063 | 0.0176376033607239 | KIRC | Male-baised eQTL |
| rs466272 | chr20:54823655:G:A | - | 0.0637148342151526 | 0.000816865669940705 | BLCA | Male-baised eQTL |
| rs462247 | chr20:54821973:C:T | - | 0.0630392321099075 | 0.000962683220448566 | BLCA | Male-baised eQTL |
| rs459656 | chr20:54821974:A:G | - | 0.0630392321099075 | 0.000962683220448566 | BLCA | Male-baised eQTL |
| rs2756957 | chr20:54822329:G:T | - | 0.0630392321099075 | 0.000962683220448566 | BLCA | Male-baised eQTL |
| rs2756958 | chr20:54822470:C:T | - | 0.0630392321099075 | 0.000962683220448566 | BLCA | Male-baised eQTL |
| rs2756959 | chr20:54822553:T:G | - | 0.0630392321099075 | 0.000962683220448566 | BLCA | Male-baised eQTL |
| rs2756960 | chr20:54822580:A:G | - | 0.0630392321099075 | 0.000962683220448566 | BLCA | Male-baised eQTL |
| rs2668395 | chr20:54822878:T:C | - | 0.0626784623175664 | 0.00104602657090502 | BLCA | Male-baised eQTL |
| rs2668394 | chr20:54823016:C:T | - | 0.0626784623175664 | 0.00104602657090502 | BLCA | Male-baised eQTL |
| rs2668396 | chr20:54822850:T:C | - | 0.0618102072420054 | 0.00155928551549008 | BLCA | Male-baised eQTL |
| rs373305065 | chr20:54812916:C:A | - | 0.0598800479297797 | 0.00384801056853998 | BLCA | Male-baised eQTL |
| rs371075682 | chr20:54812934:G:A | - | 0.0598800479297797 | 0.00384801056853998 | BLCA | Male-baised eQTL |
| rs6029839 | chr20:41835574:C:A | - | -0.0522550957551041 | 0.023936848592067 | BLCA | Male-baised eQTL |
| rs6092425 | chr20:57108959:G:A | - | 0.0650658053987279 | 0.0246415089505761 | BLCA | Male-baised eQTL |
| rs6029791 | chr20:41732145:G:T | - | -0.0599738468193829 | 0.026547239892863 | BLCA | Male-baised eQTL |
| rs67707535 | chr20:41851817:T:C | - | -0.0601548646166809 | 0.0323999698376428 | BLCA | Male-baised eQTL |
| rs116525170 | chr20:57110160:C:A | - | 0.0623864950825095 | 0.0373590228242602 | BLCA | Male-baised eQTL |
| rs6099465 | chr20:57110405:G:A | - | 0.0623864950825095 | 0.0373590228242602 | BLCA | Male-baised eQTL |
| rs2226109 | chr20:41853046:G:A | - | -0.0590738433509617 | 0.0375719271270885 | BLCA | Male-baised eQTL |
| rs4810734 | chr20:47939152:C:G | - | -0.0910450529332723 | 0.0391554732614989 | BLCA | Male-baised eQTL |
| rs8114788 | chr20:41851751:G:A | - | -0.0588190203005341 | 0.0398801200850539 | BLCA | Male-baised eQTL |
| rs67495374 | chr20:41851802:T:G | - | -0.0588190203005341 | 0.0398801200850539 | BLCA | Male-baised eQTL |
| rs6098196 | chr20:54723827:C:T | - | -0.0643220281045973 | 0.0410562015545947 | BLCA | Male-baised eQTL |
| rs6126769 | chr20:53162976:A:C | - | -0.0704048367836343 | 0.0412847404622706 | BLCA | Male-baised eQTL |
| rs7268621 | chr20:41839167:A:G | - | -0.0580576998773068 | 0.0417069932314271 | BLCA | Male-baised eQTL |
| rs6094919 | chr20:47941535:C:G | - | -0.0916351451892104 | 0.0438310711649972 | BLCA | Male-baised eQTL |
| rs4810340 | chr20:41823990:C:T | - | -0.0495958360805326 | 0.0453288962659103 | BLCA | Male-baised eQTL |
| rs6129951 | chr20:41827087:G:C | - | -0.0494249828004748 | 0.0460539918611297 | BLCA | Male-baised eQTL |
| rs67959624 | chr20:41839739:G:C | - | -0.0553231493328433 | 0.049232833906291 | BLCA | Male-baised eQTL |
| rs6124385 | chr20:41828551:C:T | - | -0.0489644220248489 | 0.0493492929202444 | BLCA | Male-baised eQTL |
| rs4812588 | chr20:42344294:T:C | - | 0.0673510821416536 | 0.0395477714320176 | COAD | Male-baised eQTL |
| rs6013798 | chr20:53790701:G:C | - | 0.0711173962176276 | 0.0465056188025379 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of CSE1L |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
